---
figid: PMC5050441__pr.115.010843f33
figlink: /pmc/articles/PMC5050441/figure/F33/
number: F33
caption: 'Multitargeted modulation of estrogen carcinogenesis by botanicals. Estrogen
  carcinogenesis involves numerous pathways: (1) Hormonal (); estrogen binds to ERα,
  which activates EREs to increase proliferation. (2) Chemical (, ); the aryl hydrocarbon
  receptor (AhR) is activated by AhR agonists, which increases P450 1A1 (benign pathway)
  and P450 1B1 (genotoxic pathway). Additionally, Nrf2-secondMaf binding to the antioxidant
  response element (ARE) increases NQO1 and phase II enzymes that detoxify genotoxic
  estrogen o-quinones, which initiate genotoxicity through DNA adducts and ROS produced
  from redox cycling between the catechol and estrogen-o-quinones. (3) Inflammatory
  (); inflammatory biomarkers, such as cytokines, increase aromatase expression, thus,
  increasing estrogen and feeding both the chemical and hormonal pathway. Cytokines,
  derived from chronic inflammation, macrophages or adipocytes, reportedly suppress
  P450 1A1, yet increase P450 1B1, most likely through the inflammatory mediator NF-κB.
  Cytokines also increase expression of genes (i.e., NF-κB, iNOS, COX-2) in epithelial
  and malignant cells that are often overexpressed in breast cancer patients. (4)
  Epigenetic (); epigenetic events through ERα inhibit expression of P450 1A1 by encouraging
  hypermethylation of its promoter, whereas having no significant effect on P450 1B1
  expression. Green arrows represent potential positive effects of botanicals, whereas
  red arrows represent negative effects in each pathway.'
pmcid: PMC5050441
papertitle: Botanicals and Their Bioactive Phytochemicals for Women’s Health.
reftext: Birgit M. Dietz, et al. Pharmacol Rev. 2016 Oct;68(4):1026-1073.
pmc_ranked_result_index: '45511'
pathway_score: 0.9551325
filename: pr.115.010843f33.jpg
figtitle: Multitargeted modulation of estrogen carcinogenesis by botanicals
year: '2016'
organisms:
- Homo sapiens
ndex: 95b72597-deeb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5050441__pr.115.010843f33.html
  '@type': Dataset
  description: 'Multitargeted modulation of estrogen carcinogenesis by botanicals.
    Estrogen carcinogenesis involves numerous pathways: (1) Hormonal (); estrogen
    binds to ERα, which activates EREs to increase proliferation. (2) Chemical (,
    ); the aryl hydrocarbon receptor (AhR) is activated by AhR agonists, which increases
    P450 1A1 (benign pathway) and P450 1B1 (genotoxic pathway). Additionally, Nrf2-secondMaf
    binding to the antioxidant response element (ARE) increases NQO1 and phase II
    enzymes that detoxify genotoxic estrogen o-quinones, which initiate genotoxicity
    through DNA adducts and ROS produced from redox cycling between the catechol and
    estrogen-o-quinones. (3) Inflammatory (); inflammatory biomarkers, such as cytokines,
    increase aromatase expression, thus, increasing estrogen and feeding both the
    chemical and hormonal pathway. Cytokines, derived from chronic inflammation, macrophages
    or adipocytes, reportedly suppress P450 1A1, yet increase P450 1B1, most likely
    through the inflammatory mediator NF-κB. Cytokines also increase expression of
    genes (i.e., NF-κB, iNOS, COX-2) in epithelial and malignant cells that are often
    overexpressed in breast cancer patients. (4) Epigenetic (); epigenetic events
    through ERα inhibit expression of P450 1A1 by encouraging hypermethylation of
    its promoter, whereas having no significant effect on P450 1B1 expression. Green
    arrows represent potential positive effects of botanicals, whereas red arrows
    represent negative effects in each pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR1
  - AHR
  - MAL
  - ESR2
  - ARNT
  - IKBKB
  - NFKB1
  - CYP19A1
  - IKBKG
  - CHUK
  - KEAP1
  - NFKBIA
  - Estrogen
  - Quinone
genes:
- word: ERa
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: ERB
  symbol: ER-beta
  source: hgnc_alias_symbol
  hgnc_symbol: ESR2
  entrez: '2100'
- word: ARNT
  symbol: ARNT
  source: hgnc_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Keap1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
- word: Quinone
  source: MESH
  identifier: D011809
diseases: []
figid_alias: PMC5050441__F33
redirect_from: /figures/PMC5050441__F33
figtype: Figure
---
